Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Clinical trial NCT03496883 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03496883
- Sponsor
- Joseph Broderick, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2028-01-01
- Enrollment
- 860
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.